2025 HCPCS Code Q2054
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: lisocabtagene viable preparation leukapheresis autologous therapeutic million| Short Description | Lisocabtagene mara car pos t |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | October 01, 2021 |
| HCPCS Action Effective Date | October 01, 2021 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4043 - Cast sup lng leg splnt ped p
- Q4044 - Cast sup lng leg splnt ped f
- Q4045 - Cast sup sht leg splnt plstr
- Q4046 - Cast sup sht leg splnt fbrgl
- Q4047 - Cast sup sht leg splnt ped p
- Q4048 - Cast sup sht leg splnt ped f
- Q4049 - Finger splint, static
- Q4050 - Cast supplies unlisted
- Q4051 - Splint supplies misc
- Q4074 - Iloprost non-comp unit dose
- Q4081 - Epoetin alfa, 100 units esrd
- Q4082 - Drug/bio noc part b drug cap
- Q4100 - Skin substitute, nos
- Q4101 - Apligraf
- Q4102 - Oasis wound matrix
- Q4103 - Oasis burn matrix
- Q4104 - Integra bmwd
- Q4105 - Integra drt or omnigraft
- Q4106 - Dermagraft
- Q4107 - Graftjacket